{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T02:14:32Z","timestamp":1769652872773,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00756-x","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:29:08Z","timestamp":1758954548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current and Investigational Biomarkers of Liver Disease in HIV-HBV Co-infection"],"prefix":"10.1007","volume":"22","author":[{"given":"Keyur","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"756_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.14309\/ajg.0000000000000231","volume":"114","author":"AY Kim","year":"2019","unstructured":"Kim AY, Hepatitis B, Virus, Coinfection HIV. Fibrosis, fat, and future directions. Am J Gastroenterol. 2019;114:710\u20132.","journal-title":"Am J Gastroenterol"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jhep.2024.01.026","volume":"80","author":"M Xu","year":"2024","unstructured":"Xu M, Warner C, Duan X, Cheng Z, Jeyarajan AJ, Li W, Wang Y, et al. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1alpha- and TGF-beta1-dependent pathway. J Hepatol. 2024;80:868\u201381.","journal-title":"J Hepatol"},{"key":"756_CR3","first-page":"14","volume":"31","author":"MA Corcorran","year":"2023","unstructured":"Corcorran MA, Kim N. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31:14\u201322.","journal-title":"Top Antivir Med"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/cid\/ciw531","volume":"63","author":"MB Klein","year":"2016","unstructured":"Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, et al. Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras. Clin Infect Dis. 2016;63:1160\u20137.","journal-title":"Clin Infect Dis"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.31823","volume":"74","author":"RK Sterling","year":"2021","unstructured":"Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, et al. A prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV co-infected adults in North America. Hepatology. 2021;74:1174\u201389.","journal-title":"Hepatology"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11904-020-00531-0","volume":"17","author":"A Cervo","year":"2020","unstructured":"Cervo A, Shengir M, Patel K, Sebastiani G. NASH in HIV. Curr HIV AIDS Rep. 2020;17:601\u201314.","journal-title":"Curr HIV AIDS Rep"},{"issue":"Suppl 2","key":"756_CR7","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1097\/QAD.0000000000001483","volume":"31","author":"G Guaraldi","year":"2017","unstructured":"Guaraldi G, Lonardo A, Maia L, Palella FJ. Jr. Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. AIDS. 2017;31(Suppl 2):S147\u201356.","journal-title":"AIDS"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/QAI.0000000000001984","volume":"81","author":"J Cai","year":"2019","unstructured":"Cai J, Sebastiani GHIV, Elevated Transaminases. Fatty liver: the perfect storm?? J Acquir Immune Defic Syndr. 2019;81:e23\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/apt.17849","volume":"59","author":"S Gawrieh","year":"2024","unstructured":"Gawrieh S, Vilar-Gomez E, Woreta TA, Lake JE, Wilson LA, Price JC, et al. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the united states. Aliment Pharmacol Ther. 2024;59:666\u201379.","journal-title":"Aliment Pharmacol Ther"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.jhep.2024.06.026","volume":"82","author":"G Sebastiani","year":"2025","unstructured":"Sebastiani G, Cinque F, Cascio A, Rockstroh JK, Guaraldi G. Inclusive healthcare in light of the new MASLD guidelines: should people living with HIV be screened for liver fibrosis? J Hepatol. 2025;82:e18-20.","journal-title":"J Hepatol"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"e3275","DOI":"10.1093\/cid\/ciaa1303","volume":"73","author":"M Khalili","year":"2021","unstructured":"Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, et al. Fatty liver disease in a prospective North American cohort of adults with human immunodeficiency virus and hepatitis B virus coinfection. Clin Infect Dis. 2021;73:e3275\u201385.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"756_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.gastha.2021.09.005","volume":"1","author":"HH Ko","year":"2022","unstructured":"Ko HH, Patel NH, Haylock-Jacobs S, Doucette K, Ma MM, Cooper C, et al. Severe hepatic steatosis is associated with low-level viremia and advanced fibrosis in patients with chronic hepatitis B in North America. Gastro Hep Advances. 2022;1(1):106\u201316.","journal-title":"Gastro Hep Advances"},{"issue":"1","key":"756_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA, et al. Aasld practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(1):321\u201357.","journal-title":"Hepatology"},{"key":"756_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000842","author":"K Patel","year":"2024","unstructured":"Patel K, Asrani SK, Fiel MI, Levine D, Leung DH, Duarte-Rojo A, et al. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: a systematic review supporting the AASLD practice guideline. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000842.","journal-title":"Hepatology"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11904-016-0329-5","volume":"13","author":"B Matta","year":"2016","unstructured":"Matta B, Lee TH, Patel K. Use of non-invasive testing to stage liver fibrosis in patients with HIV. Curr HIV AIDS Rep. 2016;13:279\u201388.","journal-title":"Curr HIV AIDS Rep"},{"key":"756_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100067","volume":"2","author":"K Patel","year":"2020","unstructured":"Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Reports. 2020;2:100067.","journal-title":"JHEP Reports"},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/j.cgh.2023.03.042","volume":"21","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Castera L, Wong VW. Noninvasive assessment of liver fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2023;21:2026\u201339.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jhep.2009.01.022","volume":"50","author":"J Bottero","year":"2009","unstructured":"Bottero J, Lacombe K, Guechot J, Serfaty L, Miailhes P, Bonnard P, et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV\/HBV co-infected patients. J Hepatol. 2009;50:1074\u201383.","journal-title":"J Hepatol"},{"key":"756_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.30825","volume":"71","author":"RK Sterling","year":"2020","unstructured":"Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, et al. Evaluating noninvasive markers to identify advanced fibrosis by liver biopsy in HBV\/HIV co-infected adults. Hepatology. 2020;71:411\u201321.","journal-title":"Hepatology"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of L","year":"2015","unstructured":"European Association for Study of L. Asociacion Latinoamericana Para El estudio Del H. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u201364.","journal-title":"J Hepatol"},{"key":"756_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041046","author":"C Bera","year":"2024","unstructured":"Bera C, Hamdan-Perez N, Patel K. Non-invasive assessment of liver fibrosis in hepatitis B patients. J Clin Med. 2024;13(4):1046. https:\/\/doi.org\/10.3390\/jcm13041046","journal-title":"J Clin Med"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2893.2010.01275.x","volume":"18","author":"P Miailhes","year":"2011","unstructured":"Miailhes P, Pradat P, Chevallier M, Lacombe K, Bailly F, Cotte L, Trabaud MA, et al. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV\/HBV-coinfected patients. J Viral Hepat. 2011;18:61\u20139.","journal-title":"J Viral Hepat"},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim WR, Berg T, Asselah T, Flisiak R, Fung S, Gordon SC, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773\u201380.","journal-title":"J Hepatol"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3851\/IMP1649","volume":"15","author":"A Boyd","year":"2010","unstructured":"Boyd A, Lasnier E, Molina JM, Lascoux-Combe C, Bonnard P, Miailhes P, et al. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term Tenofovir disoproxil fumarate use. Antivir Ther. 2010;15:963\u201374.","journal-title":"Antivir Ther"},{"key":"756_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/24731","volume":"10","author":"A Boyd","year":"2021","unstructured":"Boyd A, Dezanet LNC, Kassime R, Miailhes P, Lascoux-Combe C, Chas J, et al. Subclinical and clinical outcomes in patients coinfected with HIV and chronic hepatitis B virus from clinical outpatient centers in france: protocol for an ambispective, longitudinal cohort study. JMIR Res Protoc. 2021;10:e24731.","journal-title":"JMIR Res Protoc"},{"key":"756_CR26","doi-asserted-by":"crossref","unstructured":"Lungu GN, Diaconescu GI, Dumitrescu F, Docea AO, Mitrut R, Giubelan L, Zlatian O et al. FibroScan((R)) versus biochemical scores: A study of liver fibrosis in HIV with HBV Co-Infection. Microorganisms. 2024;12.","DOI":"10.3390\/microorganisms12061213"},{"key":"756_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw035","volume":"3","author":"J Audsley","year":"2016","unstructured":"Audsley J, Robson C, Aitchison S, Matthews GV, Iser D, Sasadeusz J, et al. Liver fibrosis regression measured by transient elastography in human immunodeficiency virus (HIV)-hepatitis B virus (HBV)-coinfected individuals on long-term HBV-active combination antiretroviral therapy. Open Forum Infect Dis. 2016;3:ofw035.","journal-title":"Open Forum Infect Dis"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.14218\/JCTH.2020.00033","volume":"8","author":"H Wei","year":"2020","unstructured":"Wei H, Song B. Elastography for longitudinal assessment of liver fibrosis after antiviral therapy: a review. J Clin Transl Hepatol. 2020;8:445\u201353.","journal-title":"J Clin Transl Hepatol"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/liv.12678","volume":"35","author":"MS Park","year":"2015","unstructured":"Park MS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, et al. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int. 2015;35:455\u201362.","journal-title":"Liver Int"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/liv.15605","volume":"43","author":"A Benmassaoud","year":"2023","unstructured":"Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, et al. Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients. Liver Int. 2023;43:1427\u201339.","journal-title":"Liver Int"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1089\/aid.2013.0004","volume":"29","author":"AD Redd","year":"2013","unstructured":"Redd AD, Wendel SK, Grabowski MK, Ocama P, Kiggundu V, Bbosa F, et al. Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis. AIDS Res Hum Retroviruses. 2013;29:1026\u201330.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s12072-011-9288-5","volume":"5","author":"J Fung","year":"2011","unstructured":"Fung J, Lai CL, Seto WK, Yuen MF. The use of transient elastography in the management of chronic hepatitis B. Hepatol Int. 2011;5:868\u201375.","journal-title":"Hepatol Int"},{"key":"756_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.101957","volume":"46","author":"J Liu","year":"2022","unstructured":"Liu J, Ma Y, Han P, Wang J, Liu YG, Shi RF, et al. Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients. Clin Res Hepatol Gastroenterol. 2022;46:101957.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"756_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000844","author":"RK Sterling","year":"2024","unstructured":"Sterling RK, Asrani SK, Levine D, Duarte-Rojo A, Patel K, Fiel MI, et al. Aasld practice guideline on noninvasive liver disease assessment of portal hypertension. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000000844.","journal-title":"Hepatology"},{"key":"756_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/hep.29893","volume":"68","author":"R Huang","year":"2018","unstructured":"Huang R, Gao ZH, Tang A, Sebastiani G, Deschenes M. Transient elastography is an unreliable marker of liver fibrosis in patients with portal vein thrombosis. Hepatology. 2018;68:783\u20135.","journal-title":"Hepatology"},{"key":"756_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/17474124.2025.2450717","volume":"19","author":"R Righetti","year":"2025","unstructured":"Righetti R, Cinque F, Patel K, Sebastiani G. The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis. Expert Rev Gastroenterol Hepatol. 2025;19:65\u201380.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"756_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108839","volume":"124","author":"H Wei","year":"2020","unstructured":"Wei H, Jiang HY, Li M, Zhang T, Song B. Two-dimensional shear wave elastography for significant liver fibrosis in patients with chronic hepatitis B: a systematic review and meta-analysis. Eur J Radiol. 2020;124:108839.","journal-title":"Eur J Radiol"},{"key":"756_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11152\/mu-942","volume":"19","author":"X Hu","year":"2017","unstructured":"Hu X, Qiu L, Liu D, Qian L. Acoustic radiation force impulse (ARFI) elastography for non\u2013invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis. Med Ultrason. 2017;19:23\u201331.","journal-title":"Med Ultrason"},{"key":"756_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015;13:440\u201351. e446.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"756_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.32151","volume":"75","author":"T Gidener","year":"2022","unstructured":"Gidener T, Yin M, Dierkhising RA, Allen AM, Ehman RL, Venkatesh SK. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: a retrospective study. Hepatology. 2022;75:379\u201390.","journal-title":"Hepatology"},{"key":"756_CR41","doi-asserted-by":"publisher","first-page":"826","DOI":"10.5604\/16652681.1171762","volume":"14","author":"AC Cardoso","year":"2015","unstructured":"Cardoso AC, Beaugrand M, de Ledinghen V, Douvin C, Poupon R, Trinchet JC, et al. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B. Ann Hepatol. 2015;14:826\u201336.","journal-title":"Ann Hepatol"},{"key":"756_CR42","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1097\/QAI.0000000000001936","volume":"80","author":"M Lemoine","year":"2019","unstructured":"Lemoine M, Assoumou L, De Wit S, Girard PM, Valantin MA, Katlama C, Necsoi C, et al. Diagnostic accuracy of noninvasive markers of steatosis, NASH, and liver fibrosis in HIV-Monoinfected individuals at risk of nonalcoholic fatty liver disease (NAFLD): results from the ECHAM study. J Acquir Immune Defic Syndr. 2019;80:e86\u201394.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"756_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/liv.12700","volume":"35","author":"MJ Nielsen","year":"2015","unstructured":"Nielsen MJ, Veidal SS, Karsdal MA, Orsnes-Leeming DJ, Vainer B, Gardner SD, Hamatake R, et al. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int. 2015;35:429\u201337.","journal-title":"Liver Int"},{"key":"756_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108544","volume":"9","author":"C Jansen","year":"2014","unstructured":"Jansen C, Leeming DJ, Mandorfer M, Byrjalsen I, Schierwagen R, Schwabl P, et al. PRO-C3-levels in patients with HIV\/HCV-co-infection reflect fibrosis stage and degree of portal hypertension. PLoS ONE. 2014;9:e108544.","journal-title":"PLoS ONE"},{"key":"756_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219526","volume":"14","author":"L Dold","year":"2019","unstructured":"Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Schierwagen R, et al. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART. PLoS ONE. 2019;14:e0219526.","journal-title":"PLoS ONE"},{"key":"756_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28222","volume":"95","author":"R Yuan","year":"2023","unstructured":"Yuan R, Zhang Y, Deng L, Yu X, Zhuang K, Chen X, et al. A novel plasma proteomic-based model for predicting liver fibrosis in HIV\/HBV co-infected adults. J Med Virol. 2023;95:e28222.","journal-title":"J Med Virol"},{"issue":"12","key":"756_CR47","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/infdis\/jiaa316","volume":"222","author":"S Naggie","year":"2020","unstructured":"Naggie S, Lusk S, Thompson JW, Mock M, Moylan C, Lucas JE, et al. Metabolomic signature as a predictor of liver disease events in patients with HIV\/HCV coinfection. J Infect Dis. 2020;222(12):2012\u201320.","journal-title":"J Infect Dis"},{"key":"756_CR48","doi-asserted-by":"crossref","unstructured":"The Liver Meeting. Boston, Massachusetts Nov 10\u201314, 2023. Hepatology 2023;78:S1\u20132154.","DOI":"10.1097\/HEP.0000000000000580"},{"key":"756_CR49","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3748\/wjg.v26.i11.1113","volume":"26","author":"DG Iacob","year":"2020","unstructured":"Iacob DG, Rosca A, Ruta SM. Circulating micrornas as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol. 2020;26:1113\u201327.","journal-title":"World J Gastroenterol"},{"key":"756_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.27369","volume":"61","author":"E Anadol","year":"2015","unstructured":"Anadol E, Schierwagen R, Elfimova N, Tack K, Schwarze-Zander C, Eischeid H, et al. Circulating micrornas as a marker for liver injury in human immunodeficiency virus patients. Hepatology. 2015;61:46\u201355.","journal-title":"Hepatology"},{"key":"756_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2024-100067","volume":"2","author":"A Cross","year":"2024","unstructured":"Cross A, Harris JM, Arbe-Barnes E, Nixon C, Dhairyawan R, Hall A, et al. Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics. eGastroenterology. 2024;2:e100067.","journal-title":"eGastroenterology"},{"key":"756_CR52","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00204-2024","author":"S Samorodnitsky","year":"2025","unstructured":"Samorodnitsky S, Weise D, Lock EF, Kunisaki KM, Morris A, Leung JM, et al. The lung proteome in HIV-associated obstructive lung disease. ERJ Open Res. 2025. https:\/\/doi.org\/10.1183\/23120541.00204-2024.","journal-title":"ERJ Open Res"},{"key":"756_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/j.gastro.2016.09.065","volume":"152","author":"B Wooden","year":"2017","unstructured":"Wooden B, Goossens N, Hoshida Y, Friedman SL. Using big data to discover diagnostics and therapeutics for gastrointestinal and liver diseases. Gastroenterology. 2017;152:53\u201367.","journal-title":"Gastroenterology"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00756-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00756-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00756-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:51Z","timestamp":1769609031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00756-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00756-x","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}